Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 30, 2000

View Archived Issues

Company Profile: Bolder Biotechnology

Progenics begins phase II pediatric trial with PRO-542

All patients dosed in trial of long-acting inhaled formulation of albuterol for asthma

Deltagen obtains license to develop potential AML treatment

FDA grants orphan drug status for Eurogene's Trinam

FeRx and Elan to develop MTC-DOX for treatment of liver cancer

Company Profile: GenStar Therapeutics

R-102444, a prodrug-type 5-HT2 antagonist, as a promising candidate for thrombosis

Maxim receives SBIR grant for development of caspase-inducing drugs

Russian antiretroviral agent effective and well tolerated in the clinic

ArQule and SmithKline Beecham partner for drug discovery

PDL to humanize antibody for InterMune

Mechanism of action of thalidomide in Crohn's disease investigated as part of clinical trial

New target for IBD treatment discussed at UEGW: leukocyte-platelet aggregation

ProdiGene receives NIH grant for development of AIDS vaccine from transgenic plants

Micrologix initiates phase Ib study for drug candidate active against S. aureus

Secondary efficacy measures improved by ISIS-2302 treatment in Crohn's disease

Abgenix and CuraGen expand genomics-based antibody drug alliance

Nonimidazole histamine H3 antagonists with excellent oral activity in mouse brain

Antibiotic properties discovered for new aromatic amides synthesized at Aventis

Nitric oxide synthase inhibitors for inflammation and pain described by AstraZeneca

Vertex presents newest JNK protein kinase inhibitors in recent patent

Preparation and use of new azepinoindole 5-HT receptor ligands from Pharmacia

Ziprasidone pharmaceutical formulations with good solubility properties

U.K. scientists investigate novel series of antitumor agents

Scotia submits additional data to FDA for Foscan NDA

Imifuramine: synthesis of a novel histamine H3 receptor agonist

Novel H3 receptor agonists show full agonist activity in vivo after oral dosing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...